Yusuf Türkmen, Cengizhan Türkoğlu, Mustafa Yıldız

Keywords: Atrial fibrillation, novel drugs


Atrial fibrillation (AF) is the most commonly encountered arrhythmia. Besides serious health problems and mortality incurred by patients, its complitacions bring about substantial economical losses. Among the most important health-related consequences are cerebrovascular and cardiovascular diseases. Therefore, convertion of AF to sinus rhythm and effective prevention from thromboembolic events are of particular importance. Despite the current availability of many rhythm control and anticoagulant medications, their efficacy and accessibility are not at a desired level. Due to adverse effects of antiarrhythmic drugs and narrow therapeutic range of anticoagulant drugs, there have been an increasing need for novel medications. There is ongoing research on the effects of many madications on AF. This paper reviews novel medicaitons in AF treatment.